Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Add-on hyaluronic acid complex with anticholinergics in male overactive bladder
KCT0004168Phase 4Completed
- Sponsor
- Metacen Therapeutics
- Start
- Oct 2019
- Countries
- 1
01
Overview
A Phase 4 trial of hyaluronic acid complex in overactive bladder (OAB), sponsored by Metacen Therapeutics. Started Oct 2019; status: completed.
02
Drugs
hyaluronic acid complex
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on KCT0004168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0004168.